GlassScriptPhysician profile
Brian Christopher Carbonell
NPI 1407388762
$2,747.34
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,422 · 2020: $910 · 2021: $170 · 2022: $245.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $1,487.06 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $313.14 | 2020 | |
| Stryker Corporation | $277.34 | 2019-2021 | |
| Smith+Nephew, INC. | $242.59 | 2019-2022 | |
| Abbott Laboratories | $142.05 | 2021-2022 | |
| Paragon 28, INC. | $85.01 | 2019-2021 | |
| Kci USA, INC. | $41.02 | 2019-2020 | |
| Organogenesis INC. | $40.84 | 2021 | |
| Aroa Biosurgery Incorporated | $27.53 | 2020 | |
| Convatec INC. | $20.13 | 2020 | |
| Kerecis Limited | $19.57 | 2021 | |
| Melinta Therapeutics, LLC | $15.41 | 2019 | |
| Zimmer Biomet Holdings, INC. | $12.58 | 2019 | |
| Medtronic Vascular, INC. | $12.57 | 2019 | |
| Boston Scientific Corporation | $10.50 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Carbonell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.